Lobbying reported · Biotechnology Innovation Organization · Jul 21Biotechnology Innovation Organization reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $2,360,000BillsH.R. 1H.R. 1492H.R. 1672H.R. 3160H.R. 3169H.R. 3269H.R. 3339H.R. 3382H.R. 3394H.R. 3521H.R. 4430H.R. 5100H.R. 5391H.R. 6423H.R. 6485H.R. 8413H.R. 9102H.R. 9142H.R. 9504S. 43S. 526S. 527S. 832S. 864S. 1096S. 1302S. 1546S. 1553S. 1573S. 1816S. 2658S. 2924S. 3014S. 3741S. 3788S. 3971
Lobbying reported · Association for Accessible Medicines · Jul 20Association for Accessible Medicines reported 2nd Quarter (Apr 1 - June 30) lobbying for Association for Accessible Medicines — $870,000BillsH.R. 3160H.R. 3269H.R. 5526H.R. 5811H.R. 6485H.R. 7148H.R. 8269H.R. 8339S. 43S. 1096S. 1546S. 1553S. 1954S. 2658S. 3469S. 3788
Lobbying reported · Blue Cross And Blue Shield Of Florida · Jul 20Blue Cross And Blue Shield Of Florida reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Of Florida — $80,000BillsH.R. 668H.R. 1227H.R. 1254H.R. 1843H.R. 2041H.R. 2493H.R. 3164H.R. 3302H.R. 3419H.R. 3514H.R. 4077H.R. 4570H.R. 4710H.R. 5243H.R. 6248H.R. 6485H.R. 6837H.R. 7895H.R. 7973H.R. 8163H.R. 8201H.R. 8209H.R. 8684H.R. 8871H.R. 8883H.R. 9117H.R. 9389H.R. 9390H.R. 9392H.R. 9393H.R. 9395H.R. 9396H.R. 9397S. 43S. 1040S. 1096S. 1302S. 1954S. 2355S. 2658S. 3014S. 3762S. 3799S. 4027S. 4189S. 4694
Lobbying reported · Blood Cancer United · Jul 20Blood Cancer United reported 2nd Quarter (Apr 1 - June 30) lobbying for Blood Cancer United — $590,000BillsH.R. 247H.R. 1509H.R. 3514H.R. 3521H.R. 5243H.R. 5526H.R. 5582H.R. 6248H.R. 6485H.R. 6867H.R. 7173H.R. 7895H.R. 8908H.R. 9260H.R. 9392H.R. 9393H.R. 9396H.R. 9397H.R. 9495H.R. 9632H.R. 9661S. 43S. 752S. 1096S. 2355S. 2658S. 3014S. 3562S. 4027S. 4494S. 4509S. 4886
Lobbying reported · Amgen · Jul 20Amgen reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $2,440,000BillsH.Con.Res. 14H.R. 1H.R. 1492H.R. 1672H.R. 3160H.R. 3269H.R. 4299H.R. 4317H.R. 5526H.R. 6166H.R. 6485H.R. 6624H.R. 7391H.R. 7837H.R. 8143H.R. 8646H.R. 8800H.R. 9102S. 2S. 43S. 1040S. 1546S. 1553S. 1954S. 2355S. 2658S. 3014S. 3345S. 3349S. 3452S. 3788S. 4323
Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5371H.R. 6089H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.R. 9661H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 1040S. 1071S. 1096S. 1387S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
Lobbying reported · American Intellectual Property Law Association · Jul 20American Intellectual Property Law Association reported 2nd Quarter (Apr 1 - June 30) lobbying for American Intellectual Property Law Association — $10,000BillsH.R. 1109H.R. 1566H.R. 2675H.R. 3160H.R. 3269H.R. 4930H.R. 5794H.R. 5811H.R. 6028H.R. 6485H.R. 6517H.R. 7140S. 43S. 1096S. 1367S. 1546S. 1553S. 2677S. 3517
Lobbying reported · American Society Of Health-System Pharmacists · Jul 20American Society Of Health-System Pharmacists reported 2nd Quarter (Apr 1 - June 30) lobbying for American Society Of Health-System Pharmacists — $260,000BillsH.R. 929H.R. 1561H.R. 1708H.R. 1768H.R. 2004H.R. 3164H.R. 3269H.R. 3514H.R. 3789H.R. 4122H.R. 4581H.R. 5526H.R. 5880H.R. 6485H.R. 7184H.R. 7994H.R. 8005H.R. 8646H.R. 9396H.R. 9661S. 266S. 1954S. 2426S. 2658S. 3014
Lobbying reported · Public Citizen · Jul 20Public Citizen reported 2nd Quarter (Apr 1 - June 30) lobbying for Public Citizen — $99,577BillsH.R. 425H.R. 1492H.R. 3069H.R. 3140H.R. 3269H.R. 3513H.R. 4305H.R. 5106H.R. 5298H.R. 5336H.R. 5427H.R. 6145H.R. 6191H.R. 6485H.R. 6731H.R. 7008H.R. 7219H.R. 7802H.R. 7806H.R. 7955H.R. 8123H.R. 8309S. 43S. 832S. 1040S. 1096S. 1814S. 1941S. 2845S. 3210S. 3956S. 3991S. 4017S. 4189S. 4246S. 4299S. 4545
Lobbying reported · Blue Cross And Blue Shield Association · Jul 20Blue Cross And Blue Shield Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Association — $990,000BillsH.R. 668H.R. 1227H.R. 1254H.R. 1843H.R. 2041H.R. 2493H.R. 3164H.R. 3302H.R. 3419H.R. 3514H.R. 4077H.R. 4570H.R. 4710H.R. 5243H.R. 6248H.R. 6485H.R. 6837H.R. 7895H.R. 7973H.R. 7996H.R. 8163H.R. 8201H.R. 8209H.R. 8684H.R. 8871H.R. 8883H.R. 9117H.R. 9389H.R. 9390H.R. 9392H.R. 9393H.R. 9395H.R. 9396H.R. 9397S. 43S. 1040S. 1096S. 1302S. 1954S. 2355S. 2556S. 2658S. 3014S. 3762S. 3799S. 4027S. 4189S. 4694
Lobbying reported · Guidewell Mutual Holding · Jul 20Guidewell Mutual Holding reported 2nd Quarter (Apr 1 - June 30) lobbying for Guidewell Mutual Holding — $20,000BillsH.R. 668H.R. 1227H.R. 1843H.R. 3164H.R. 3514H.R. 4077H.R. 4570H.R. 5243H.R. 6485H.R. 6837H.R. 7895H.R. 8163H.R. 8871H.R. 8883H.R. 9392H.R. 9395S. 43S. 1040S. 1096S. 1302S. 1954S. 2658S. 3014S. 3762S. 4189
Lobbying reported · Council for Innovation Promotion · Jul 20Council for Innovation Promotion reported 2nd Quarter (Apr 1 - June 30) lobbying for Council for Innovation Promotion — $90,000BillsH.R. 861H.R. 2794H.R. 3269H.R. 4370H.R. 4780H.R. 6485H.R. 9221H.R. 9474S. 43S. 527S. 1040S. 1367S. 2140S. 2220S. 2780S. 4840
Lobbying reported · Apotex · Jul 20Apotex reported 2nd Quarter (Apr 1 - June 30) lobbying for Apotex — $730,000BillsH.R. 5526H.R. 6485S. 43S. 1954
Lobbying reported · Glaxosmithkline · Jul 16Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5509H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7391H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 891S. 1040S. 1071S. 1096S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
Lobbying reported · Intellectual Property Owners Association · Jul 15Intellectual Property Owners Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Intellectual Property Owners Association — $50,000BillsH.R. 1566H.R. 3160H.R. 3269H.R. 5155H.R. 6485H.R. 7015H.R. 7389H.R. 8800S. 43S. 1379S. 1546S. 1553S. 2658S. 3826S. 4784